Market Cap : 8.55 B | Enterprise Value : 8.49 B | P/E (TTM) : | P/B : 73.55 |
---|
NAS:NVAX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NVAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Novavax's Enterprise Value is $8,489.4 Mil. Novavax's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-259.3 Mil. Therefore, Novavax's EV-to-EBIT for today is -32.74.
During the past 13 years, the highest EV-to-EBIT of Novavax was -1.30. The lowest was -120.90. And the median was -7.10.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Novavax's Enterprise Value for the quarter that ended in Sep. 2020 was $6,606.0 Mil. Novavax's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-259.3 Mil. Novavax's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was -3.92%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Novavax's EV-to-EBIT falls into.
Novavax's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 8489.382 | / | -259.28 | |
= | -32.74 |
Novavax's current Enterprise Value is $8,489.4 Mil.
Novavax's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -28.783 (Dec. 2019 ) + -22.817 (Mar. 2020 ) + -14.474 (Jun. 2020 ) + -193.206 (Sep. 2020 ) = $-259.3 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Novavax's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2020 ) | = | EBIT | / | Enterprise Value (Q: Sep. 2020 ) |
= | -259.28 | / | 6605.9829 | |
= | -3.92 % |
Novavax's Enterprise Value for the quarter that ended in Sep. 2020 was $6,606.0 Mil.
Novavax's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -28.783 (Dec. 2019 ) + -22.817 (Mar. 2020 ) + -14.474 (Jun. 2020 ) + -193.206 (Sep. 2020 ) = $-259.3 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline